MUMBAI, May 23 (Reuters) - Drug maker Alembic Ltd. said on Wednesday it had signed a deal to out-license its novel drug delivery platform to Belgium's UCB for the latter's anti-epileptic drug Keppra ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results